Current status and future expectations of nanobodies in oncology trials.

Saved in:
Bibliographic Details
Title: Current status and future expectations of nanobodies in oncology trials.
Authors: De Pauw T; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., De Mey L; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium., Debacker JM; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium., Raes G; Cellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., Van Ginderachter JA; Cellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., De Groof TWM; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Devoogdt N; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.
Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2023 Jul-Dec; Vol. 32 (8), pp. 705-721. Date of Electronic Publication: 2023 Aug 28.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-7658
DOI:10.1080/13543784.2023.2249814